贝伐单抗与博来霉素联合治疗单独硬化治疗无效的眼眶淋巴管瘤样静脉畸形。 - Suppr

Bevacizumab and Bleomycin combination for treatment of orbital lymphatico-venous malformation recalcitrant to sclerosing therapy alone.

作者信息

Mustak Hamzah, Ugradar Shoaib, Goldberg Robert, Rootman Daniel

机构信息

Groote Schuur Hospital, Division of Ophthalmology, University of Cape Town, Cape Town, South Africa.

Stein Eye Institute, Division of Orbital and Oculoplastic Surgery, University of California, Los Angeles, California, USA.

出版信息

Clin Exp Ophthalmol. 2018 Sep;46(7):815-816. doi: 10.1111/ceo.13159. Epub 2018 Feb 23.

DOI:10.1111/ceo.13159

PMID:29369465

Abstract

摘要

相似文献

Bevacizumab and Bleomycin combination for treatment of orbital lymphatico-venous malformation recalcitrant to sclerosing therapy alone.

Clin Exp Ophthalmol. 2018 Sep;46(7):815-816. doi: 10.1111/ceo.13159. Epub 2018 Feb 23.

Bleomycin sclerotherapy of a distensible orbital venous malformation without image guidance.

Can J Ophthalmol. 2019 Jun;54(3):e120-e123. doi: 10.1016/j.jcjo.2018.08.016. Epub 2018 Nov 23.

Preliminary experience of percutaneous intralesional bleomycin injection for the treatment of orbital lymphatic-venous malformation refractory to surgery.

Clin Radiol. 2012 Feb;67(2):182-4. doi: 10.1016/j.crad.2011.08.021. Epub 2011 Oct 21.

Bevacizumab and interferon reduce venous recanalization following sclerotherapy.

J Pediatr Surg. 2016 Oct;51(10):1670-3. doi: 10.1016/j.jpedsurg.2016.06.009. Epub 2016 Jun 16.

Image-Guided Percutaneous Bleomycin and Bevacizumab Sclerotherapy of Orbital Lymphatic Malformations in Children.

Cardiovasc Intervent Radiol. 2019 Mar;42(3):433-440. doi: 10.1007/s00270-018-2128-4. Epub 2018 Nov 28.

Bleomycin electrosclerotherapy: new treatment to manage vascular malformations.

Br J Oral Maxillofac Surg. 2017 Nov;55(9):977-979. doi: 10.1016/j.bjoms.2017.10.002. Epub 2017 Oct 18.

Role of intralesional bleomycin sclerotherapy as the sole or adjunct treatment of superficial ocular adnexal lymphatic malformations.

Eye (Lond). 2018 Jan;32(1):152-155. doi: 10.1038/eye.2017.154. Epub 2017 Aug 4.

Bleomycin sclerotherapy for extensive lympho-venous malformation. a retrospective analysis of a patient's death.

Eur J Pediatr Surg. 2011 Mar;21(2):134-6. doi: 10.1055/s-0030-1261883. Epub 2010 Jul 28.

Intralesional bleomycin injection in management of low flow vascular malformations in children.

J Plast Surg Hand Surg. 2015 Apr;49(2):116-20. doi: 10.3109/2000656X.2014.951051. Epub 2014 Sep 10.

Bleomycin sclerotherapy for eyelid venous malformations as an alternative to surgery or laser therapy.

J Neurointerv Surg. 2019 Jan;11(1):57-61. doi: 10.1136/neurintsurg-2018-013813. Epub 2018 Apr 19.

引用本文的文献

Classification, diagnosis, and management of orbital venous-lymphatic malformations: Current state-of-the-art.

Taiwan J Ophthalmol. 2025 Mar 10;15(1):4-13. doi: 10.4103/tjo.TJO-D-24-00151. eCollection 2025 Jan-Mar.

Vascular Endothelial Growth Factor Receptor Expression in Orbital Cavernous Malformations and Lymphatic Malformations.

Ophthalmol Vis Care. 2021;1(1). Epub 2021 Mar 31.

Clinical Assessment and Lesion-Specific Management of Orbital Vascular Malformations.

J Neurol Surg B Skull Base. 2021 Feb;82(1):116-128. doi: 10.1055/s-0040-1722702. Epub 2021 Mar 23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Bevacizumab and Bleomycin combination for treatment of orbital lymphatico-venous malformation recalcitrant to sclerosing therapy alone.

作者信息

Mustak Hamzah, Ugradar Shoaib, Goldberg Robert, Rootman Daniel

机构信息

Groote Schuur Hospital, Division of Ophthalmology, University of Cape Town, Cape Town, South Africa.

Stein Eye Institute, Division of Orbital and Oculoplastic Surgery, University of California, Los Angeles, California, USA.

出版信息

Clin Exp Ophthalmol. 2018 Sep;46(7):815-816. doi: 10.1111/ceo.13159. Epub 2018 Feb 23.

DOI:10.1111/ceo.13159

PMID:29369465

Abstract

摘要

相似文献

Bevacizumab and Bleomycin combination for treatment of orbital lymphatico-venous malformation recalcitrant to sclerosing therapy alone.

Clin Exp Ophthalmol. 2018 Sep;46(7):815-816. doi: 10.1111/ceo.13159. Epub 2018 Feb 23.

Bleomycin sclerotherapy of a distensible orbital venous malformation without image guidance.

Can J Ophthalmol. 2019 Jun;54(3):e120-e123. doi: 10.1016/j.jcjo.2018.08.016. Epub 2018 Nov 23.

Preliminary experience of percutaneous intralesional bleomycin injection for the treatment of orbital lymphatic-venous malformation refractory to surgery.

Clin Radiol. 2012 Feb;67(2):182-4. doi: 10.1016/j.crad.2011.08.021. Epub 2011 Oct 21.

Bevacizumab and interferon reduce venous recanalization following sclerotherapy.

J Pediatr Surg. 2016 Oct;51(10):1670-3. doi: 10.1016/j.jpedsurg.2016.06.009. Epub 2016 Jun 16.

Image-Guided Percutaneous Bleomycin and Bevacizumab Sclerotherapy of Orbital Lymphatic Malformations in Children.

Cardiovasc Intervent Radiol. 2019 Mar;42(3):433-440. doi: 10.1007/s00270-018-2128-4. Epub 2018 Nov 28.

Bleomycin electrosclerotherapy: new treatment to manage vascular malformations.

Br J Oral Maxillofac Surg. 2017 Nov;55(9):977-979. doi: 10.1016/j.bjoms.2017.10.002. Epub 2017 Oct 18.

Role of intralesional bleomycin sclerotherapy as the sole or adjunct treatment of superficial ocular adnexal lymphatic malformations.

Eye (Lond). 2018 Jan;32(1):152-155. doi: 10.1038/eye.2017.154. Epub 2017 Aug 4.

Bleomycin sclerotherapy for extensive lympho-venous malformation. a retrospective analysis of a patient's death.

Eur J Pediatr Surg. 2011 Mar;21(2):134-6. doi: 10.1055/s-0030-1261883. Epub 2010 Jul 28.

Intralesional bleomycin injection in management of low flow vascular malformations in children.

J Plast Surg Hand Surg. 2015 Apr;49(2):116-20. doi: 10.3109/2000656X.2014.951051. Epub 2014 Sep 10.

Bleomycin sclerotherapy for eyelid venous malformations as an alternative to surgery or laser therapy.

J Neurointerv Surg. 2019 Jan;11(1):57-61. doi: 10.1136/neurintsurg-2018-013813. Epub 2018 Apr 19.

引用本文的文献

Classification, diagnosis, and management of orbital venous-lymphatic malformations: Current state-of-the-art.

Taiwan J Ophthalmol. 2025 Mar 10;15(1):4-13. doi: 10.4103/tjo.TJO-D-24-00151. eCollection 2025 Jan-Mar.

Vascular Endothelial Growth Factor Receptor Expression in Orbital Cavernous Malformations and Lymphatic Malformations.

Ophthalmol Vis Care. 2021;1(1). Epub 2021 Mar 31.

Clinical Assessment and Lesion-Specific Management of Orbital Vascular Malformations.

J Neurol Surg B Skull Base. 2021 Feb;82(1):116-128. doi: 10.1055/s-0040-1722702. Epub 2021 Mar 23.

Bevacizumab and Bleomycin combination for treatment of orbital lymphatico-venous malformation recalcitrant to sclerosing therapy alone.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Bevacizumab and Bleomycin combination for treatment of orbital lymphatico-venous malformation recalcitrant to sclerosing therapy alone.

作者信息

机构信息

出版信息

相似文献

引用本文的文献